Last updated: 2026-10-13 22:01:00. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
ClearPoint Neuro, Inc. (CLPT) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $9.83, with a market capitalization of $319.68M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $8.27 to $28.10. This page covers its latest market performance, valuation, price trends and company information.
$319.68M | |
$10.17 | |
$31.29 | |
$2.86 | |
$10.20 | |
744.64K | |
644.01K | |
-- | |
$28.10 | |
$8.27 | |
-- | |
-- |
ClearPoint Neuro, Inc. (CLPT) is trading at $9.83 in after-hours trading as of 2026-10-13 20:34:00, down 3.63% ($0.37) from the regular-session close of $10.20.
After-hours trading shows how investors are pricing CLPT after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.
Over the past seven days, ClearPoint Neuro, Inc. (CLPT) moved from $10.90 to $9.83, representing a decline of 9.81% ($1.07).
The stock traded between $9.74 and $11.74 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 644.86 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 7.8%
CLPT is currently trading at $9.83, placing it 7.8% of the way from its 52-week low of $8.27 to its 52-week high of $28.10. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 172 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of ClearPoint Neuro, Inc. (CLPT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.